The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR and Partners Help Get Legislation Passed in New York to Limit Step Therapy

The ACR and Partners Help Get Legislation Passed in New York to Limit Step Therapy

August 4, 2016 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In June, state lawmakers in New York passed legislation on step therapy designed to help ensure patient access to the best and most appropriate care.

You Might Also Like
  • Step Therapy, Biosimilars among ACR’s 2017 State-Level Priorities
  • The ACR’s Advocacy at State Legislature Level in 2016 Focuses on Biosimilars, Step Therapy
  • Ohio Rheumatologists Advocate for Step Therapy Reform & More
Also By This Author
  • ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints

Step therapy mandates that a patient with a specific condition receive prescribed drugs approved for that condition in the order that an insurance company determines it will cover as the first, second, third, etc., line of treatment. Sometimes the order of prescribed drugs is different than the order preferred by the physician, but the patient must comply with the step therapy protocol or the insurer likely won’t pay for treatment.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

[Editor’s note: Check out one patient’s story in Massachusetts, where legislation on step therapy is pending.]

Legislative Requirements
The bill (A2834D, 2016) specifically requires health insurance companies to:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Base step therapy on appropriate clinical practice guidelines or published peer review data;
  • Exempt patients from step therapy when it is inappropriate or not in the best interest of the patient, and
  • Allow patients access to a “fair, transparent, and independent process for requesting an exception to a step therapy protocol when the patients’ physician deems appropriate.” (See A2834D. Assemb. Reg. Less. 2015-2016. NY 2016.)

“The legislation will provide accelerated pathways to override step therapy when medically appropriate,” says Howard Blumstein, MD, a member of the New York State Rheumatology Society and chair of the American College of Rheumatology (ACR) Affiliate Societies Council.

Where the ACR Stands
Saying that the ACR is not inherently opposed to the concept of step therapy and recognizes its use by insurance companies to control cost, Dr. Blumstein emphasized, however, that step therapy can impede patients from accessing needed medications.

“Many patients are faced with changing insurance plans, and often, each insurer will have its own set of step therapy protocols,” he says. “If a patient is stable on a medication and they switch plans, they should not have to fail a medication that they [have] tried previously to satisfy insurance requirements.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In recognition of the many rheumatology patients for whom stable and consistent treatment is necessary, the ACR Affiliate Society Council collaborated with the New York State Rheumatology Society, the Arthritis Foundation, the Lupus and Allied Diseases Association, and the Lupus Agencies of New York State to lobby for the legislation. One of the primary missions of the ACR Affiliate Society Council is to help state rheumatology societies develop and flourish, and assist in promoting best practices for advocacy at the state level.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: Legislation & Advocacy, step therapy

You Might Also Like:
  • Step Therapy, Biosimilars among ACR’s 2017 State-Level Priorities
  • The ACR’s Advocacy at State Legislature Level in 2016 Focuses on Biosimilars, Step Therapy
  • Ohio Rheumatologists Advocate for Step Therapy Reform & More
  • Texas Rheumatologists Push for Passage of Step Therapy Reforms

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.